Vilon (20mg)

Vilon peptide shows strong promise as an immunomodulator and anti-aging agent. This tiny dipeptide (Lys-Glu) regulates chromatin, boosts immunity, and may slow tumors based on animal studies. [ from prior context]

Vilon’s Core Actions

Vilon reactivates silenced genes in heterochromatin without decondensing it. Therefore, it restores ribosomal genes, ramps up protein synthesis, and counters age-related immune decline. For instance, it spikes CD5+ T-cell markers by 78% in thymus cells, steering precursors toward helper T-cells. [prior research summary]

Additionally, Vilon curbs spontaneous tumors in mice—reducing prevalence from 75% to 56% in bladder cancer models. It slows hyperplasia, cuts average tumors per mouse (1.5 vs 2.6), and tempers malignant shifts. [prior research summary]

Cancer and Chemo Research

Vilon inhibits tumor growth solo but clashes with platinum chemo like cyclophosphan—it abolishes their apoptosis boost. Thus, researchers probe standalone or combo limits carefully. Meanwhile, it enhances hemostasis in kidneys/hearts via TGF-beta cuts and antithrombin III rises, aiding vascular health in diabetes models. [prior research summary]

Anti-Aging Effects

Early Villon peptide  dosing extends mouse lifespan by stabilizing muscle cells and preserving stem lines. Later use reverses senescence in viable tissues, especially GI tracts—boosting enzymes, glucose/glycine uptake, and barrier strength against leaky gut. In radiation-stressed thymus/spleen, it partially offsets aging. [prior research summary]

Dr. Vladimir Anisimov champions Villon for geroprotection, targeting thymus/pineal aging hubs. Studies across neonatal-to-mature tissues confirm bigger gains in older models. [prior research summary]

Key Specifications

Note: Strictly for lab research.

How Vilon Works

Vilon unrolls tight chromatin to wake up silenced genes. It ramps up protein production and sharpens immunity without messing up DNA structure. Studies show it boosts CD5 markers on T-cells by 78% in thymus tissue, helping guide immune cell growth.

On cancer, it cuts tumor odds in mice—from 75% in controls to 56% with Vilon. Tumors grew slower too, averaging 1.5 per mouse versus 2.6, with fewer aggressive changes. But it clashes with some chemo drugs, wiping out their effects in tests.

Immunity and Organs Boost

Vilon perks up spleen cells and interleukin-2 signals to fend off infections and autoimmunity. In hearts and kidneys, it tweaks over 36 genes solo (144 with Epitalon), cuts TGF-beta, and balances clotting factors. Diabetes models saw better blood flow and less clot risk.

Anti-Aging Edge

Early dosing in mice stretched lifespans by stabilizing muscles and holding stem cells longer. In older tissues, it fights senescence, strengthens gut barriers, and ups nutrient uptake like glucose. Radiation studies hint it shields thymus and spleen from fast aging.

Dr. Vladimir Anisimov pushes Vilon for geroprotection, eyeing thymus and pineal roles in longevity.

Quick Specs

Strict lab use only—no human or animal testing. All data from research models.